A Phase 2 Randomized, Human Growth Hormone-controlled, multicenter Basket study of Vosoritide in Children with Turner Syndrome, Short Stature Homeobox-containing Gene Deficiency, and Noonan Syndrome with and inadequate response to Human Growth Hormone.
